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RESEARCH ARTICLE
Myc activity is required for maintenance of the neuromesodermal
progenitor signalling network and for segmentation clock gene
oscillations in mouse
Ioanna Mastromina, Laure Verrier, Joana Clara Silva, Kate G. Storey and J. Kim Dale*
ABSTRACT
TheMyc transcriptional regulators are implicated in a range of cellular
functions, including proliferation, cell cycle progression, metabolism
and pluripotency maintenance. Here, we investigated the expression,
regulation and function of the Myc family during mouse embryonic
axis elongation and segmentation. Expression of both cMyc (Myc –
Mouse Genome Informatics) and MycN in the domains in which
neuromesodermal progenitors (NMPs) and underlying caudal
pre-somitic mesoderm (cPSM) cells reside is coincident with WNT
and FGF signals, factors known to maintain progenitors in an
undifferentiated state. Pharmacological inhibition of Myc activity
downregulates expression of WNT/FGF components. In turn, we find
that cMyc expression is WNT, FGF and Notch protein regulated,
placing it centrally in the signalling circuit that operates in the tail end
that both sustains progenitors and drives maturation of the PSM into
somites. Interfering with Myc function in the PSM, where it displays
oscillatory expression, delays the timing of segmentation clock
oscillations and thus of somite formation. In summary, we identify
Myc as a component that links NMPmaintenance and PSMmaturation
during the body axis elongation stages of mouse embryogenesis.
KEY WORDS: Myc, Neuromesodermal progenitors, Segmentation
clock, Embryo, Presomitic mesoderm
INTRODUCTION
The Myc proto-oncogene family is one of the most exhaustively
studied families of vertebrate genes (Eilers and Eisenman, 2008;
Meyer and Penn, 2008). Since the discovery of cMyc (in chick)
(Alitalo et al., 1983; Watson et al., 1983), two more members were
identified, namely MYCN (Brodeur et al., 1984; Emanuel et al.,
1985) and L-MYC (MYCL – Human Gene Nomenclature Database)
(Ikegaki et al., 1989; Nau et al., 1985), and a plethora of studies has
placed eachmember centrally in tumorigenesis, in a context-specific
manner (Tansey, 2014). It is now established that the oncogenic
potential of Myc is mediated through the transcriptional control of
multiple target gene sets (Dang et al., 2006; Zeller et al., 2003,
2006). Myc contains a basic helix-loop-helix (bHLH) domain and
transcriptional activation takes place when it heterodimerizes with
Max (Blackwood and Eisenman, 1991; Blackwood et al., 1991),
and repression when it dimerizes with Miz1 (Staller et al., 2001).
Additional co-factors, such as the bromodomain-containing protein
BRD4, mediate recruitment of the Myc complex onto the chromatin
(Delmore et al., 2011).
The discovery of cMyc as one of the four Yamanaka factors
(Takahashi and Yamanaka, 2006) has highlighted multiple roles
forMyc within the pluripotent cell state (Fagnocchi and Zippo, 2017).
During embryogenesis, Myc has been implicated in the metabolic
regulation of the pre-implantation embryo (Scognamiglio et al., 2016),
progenitor sorting and cell competition in the early postimplantation
epiblast (Clavería et al., 2013; Sancho et al., 2013), maintenance of
the neural crest progenitor pool (Kerosuo and Bronner, 2016) and
neural differentiation progression (Zinin et al., 2014).
Both cMyc and MycN homozygote mutant mice are embryonic
lethal, displaying a range of defects (Davis et al., 1993; Sawai et al.,
1993; Trumpp et al., 2001), suggesting that the Myc factors hold
important roles during development and, likely, in a context-specific
manner. Expression pattern analyses indicate the presence of both
cMyc and MycN in multiple embryonic tissues (Downs et al., 1989;
Kato et al., 1991; Ma et al., 2014). However, these data, based on
radiolabelled probes, give very low definition and low signal-to-noise
ratio, and, as such, cannot be utilized to decipher precise patterns of
expression. For example, detailed expression pattern and specific
functions of the Myc genes during elongation and segmentation of
the embryo body axis has yet to be investigated, with respect to the
different progenitor subpopulations that comprise the tail region
(Wymeersch et al., 2016). In particular, the embryonic day (E)
8.5 postimplantation epiblast is a heterogeneous domain in which
progenitors with different developmental potentials reside (Henrique
et al., 2015; Wilson et al., 2009; Wymeersch et al., 2016).
Key to this study, detailed fate mapping and clonal analysis has
indicated that posterior neural and mesoderm lineages emerge from
a common progenitor population, termed the neuromesodermal
progenitors (NMPs) (Cambray and Wilson, 2002; Cambray and
Wilson, 2007; Delfino-Machín et al., 2005; Tzouanacou et al.,
2009). NMPs have been identified in human, mouse, chicken and
zebrafish embryos (Goto et al., 2017; Olivera-Martinez et al., 2012;
Wymeersch et al., 2016), and have been generated in vitro from both
mouse and human embryonic stem cells (ESCs) (Gouti et al., 2017;
Gouti et al., 2014; Tsakiridis et al., 2014; Turner et al., 2014; Verrier
et al., 2018). In the mouse embryo, NMPs first arise at E7.5, in the
domain of the node streak border (NSB) and associated caudal-
lateral epiblast (CLE), persist in the NSB and CLE at E8.5, and are
subsequently incorporated in the chordo-neural hinge (CNH) during
tail growth stages (Henrique et al., 2015). Importantly, the dual-
fated NMPs supply cells to both the forming neural plate (open pre-
neural tube) and to the caudal pre-somitic mesoderm (cPSM) (Gouti
et al., 2014; Rodrigo Albors et al., 2016 preprint; Tzouanacou et al.,Received 31 October 2017; Accepted 8 June 2018
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2009), which further matures and segments rostrally to form the
somites. The NMPs and cPSM cells are maintained in an
‘undifferentiated’ progenitor state, mainly through the activity of
WNT and FGF signals, components of which show very high
expression in the posterior of the embryo (Hubaud and Pourquié,
2014; Wilson et al., 2009). In addition, WNT, FGF and Notch
signalling pathways comprise the segmentation clock, a molecular
oscillator which regulates the periodic segmentation of the pre-
somitic mesoderm (PSM) into somites (Hubaud and Pourquié,
2014; Maroto et al., 2012). Concomitantly, neural and somitic
differentiation is promoted by retinoic acid (RA), which is produced
by the somatic tissue and counteracts WNT/FGF signalling
(Delfino-Machín et al., 2005; Dequeant and Pourquie, 2008; Diez
del Corral et al., 2003; Dubrulle and Pourquié, 2004; Naiche et al.,
2011; Olivera-Martinez and Storey, 2007; Sakai et al., 2001).
Interestingly, cMyc has been shown to be present and to display
dynamic oscillatory mRNA expression in the PSM (Dequeant et al.,
2006; Krol et al., 2011), while also being expressed at high levels in
the domain that harbours the NMPs in the chicken embryo (Olivera-
Martinez et al., 2014). However, no investigation as to the
functional significance of Myc expression in these domains has
been conducted.
Here, we elucidate divergent roles for Myc during posterior
embryonic body axis formation. We find that cMyc is indispensable
for the proper timing of clock gene oscillations through regulation of
Notch signalling. Moreover, we demonstrate that Myc operates in a
positive feedback loop with WNT and FGF signalling in the CLE of
the E8.5 embryo, and that inhibition of Myc activity results in
transcriptional downregulation of different gene sets, which include
regulators of metabolism. These findings are the first to provide a
common regulator of different sets of genes that coordinate
progenitor cell maintenance, metabolism and differentiation in the
NMPs and cPSM in the mouse embryo.
RESULTS
cMyc is expressed in the CLE and underlying cPSM and its
expression persists during axial elongation and body axis
segmentation
We generated cMyc and MycN riboprobes and carried out an initial
expression pattern analysis (Fig. 1). We were particularly interested
to see that both Myc members show high levels of expression in the
posterior of the embryo proper. We find high levels of cMyc in
the CLE domain, and lower levels in the underlying cPSM
(Fig. 1Ba,a′). MycN exhibits a complementary expression pattern:
Fig. 1. cMyc is co-expressed with Wnt3a, Fgf8, Sox2 and brachyury in the CLE. (A) Representative confocal images of an E8.5 embryo labelled by
immunofluorescence for Sox2 and brachyury (n=3 embryos). (a) Whole-mount E8.5 embryo and (b-d) transverse sections at the level of the CLE domain
(demarcated by thewhite dashed line in a). Sox2 labels the neuroepithelium along the anterior-posterior axis and the CLE, whereas brachyury labels the PSMand
tail bud mesoderm. (e) Magnification of d, showing the location of the NMPs (Sox2/brachyury co-expressing cells) in the CLE epithelium. (B) Representative
in situ hybridization (ISH) images of E8.5 embryos labelled for (a) cMyc (n=10 embryos), (b) MycN (n=4 embryos), (c) Fgf8 (n=3 embryos), (d) Wnt3a (n=3
embryos) and (e) Lfringe (n=5 embryos). (a′-e′) Transverse sections of the CLE and underlying cPSM domain indicated by the white dashed lines in a-e.
(a′) cMyc, (c′) Fgf8 and (d′)Wnt3a show high levels of expression in the CLE. (b′) MycN and (e′) Lfringe show high levels of expression in the cPSM.
(C) Representative confocal images of immunofluorescence labelling of E8.5 embryos for cMyc and Sox2 (a-g; n=3 embryos) and cMyc and brachyury (h-n; n=3
embryos). Sox2/cMyc co-expressing cells are evident in the transverse sections of the CLE (e-g; panels correspond to sections at the level of the domain
demarcated by the white dashed line in a). Brachyury/cMyc co-expressing cells are evident both in the CLE and underlying cPSM (l-n; panels correspond to the
white dashed line in e). Scale bars: 100 μm.
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low in CLE and higher in the underlying cPSM (Fig. 1Bb,b′). The
CLE is the region in which a small bipotent population of precursors
is located, namely the NMPs. These cells can be visualized by the
co-expression of Sox2 and brachyury (Fig. 1A) and maintenance of
their bipotency relies on autocrine and paracrine WNT/FGF
signalling. We find that both Myc factors are expressed alongside
Wnt3a and Fgf8 in the CLE and alongside the Notch target gene
Lfringe (Lfng) (Dale et al., 2003; McGrew et al., 1998) in the cPSM
(Fig. 1B). Using immunofluorescence, we find that cMyc is co-
expressed with Sox2 and brachyury in the CLE and underlying
cPSM (Fig. 1C). These expression data therefore show that mouse
NMPs co-express cMyc, WNT3A, FGF8, Sox2 and brachyury.
Crosstalk between cMyc and FGF (Yu et al., 2017) or WNT
(Fagnocchi et al., 2016) proteins or Sox2 (Lin et al., 2009) has been
reported in other systems. It is therefore likely that cMyc might be
involved in the NMP signalling network.
cMyc is expressed in the tail bud at E9.5 and E10.5 and
displays oscillatory mRNA expression in the PSM
We further characterized expression of cMyc and MycN during E9.5
and E10.5, the embryonic stages in which the anterio-posterior
axis elongates and segments into somites (Gibb et al., 2010; Henrique
et al., 2015). The tail bud mesoderm is the main reservoir of cPSM
progenitors, whereas the caudal-most, Sox2/brachyury-positive
region of the neuroepithelium harbours the NMPs. Using in situ
hybridization (ISH), we find that cMyc displays dynamic mRNA
expression in the PSM, reminiscent of clock gene expression
(Fig. 2Ad), consistent with previously published data in mouse and
chickPSM(Dequeant et al., 2006;Krol et al., 2011).We find that cMyc
protein is expressed in the caudal-most neuroepithelium (labelled by
Sox2 and brachyury) and adjacent tail bud mesoderm (labelled by
brachyury) (Fig. 2B).MycN is expressed in the E9.5 tail bud; however,
its expression is downregulated at E10.5 and E11.5 (Fig. S1).
Fig. 2. cMyc expression persists in the tail bud during E9.5-E10.5 and showsdynamic expression at the transcript level. (A) Representative ISH images of
a tail bad at E9.5 and E10.5. (a) Whole-mount E9.5 embryo labelled for cMyc at E9.5 (n=12 embryos). (b,b′) High levels of cMyc are present in the caudal-most
neuroepithelium and adjacent PSM (arrowheads). (c) Side view of an E10.5 tail labelled for cMyc mRNA. (d) Three different expression profiles for cMyc in the
PSM of E10.5 embryos, reminiscent of the three phases of segmentation clock gene expression (n=10 embryos). (B) Representative confocal images of
immunofluorescence labelling for cMyc in E9.5 and E10.5 embryos. (a-f ) cMyc and brachyury staining in whole-mount embryos. (a′-f′) Higher magnification
images of a-f showing cMyc/brachyury co-expressing cells in the tail bud (n=5 embryos). (g-l) cMyc and Sox2 labelling in whole-mount embryos. (g′-l′) Higher
magnification images of g-l, showing cMyc/Sox2 co-expressing cells in the tail bud (n=5 embryos). Scale bars: 100 μm.
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Suppression of Myc activity attenuates expression of key
FGF/WNT network components, leading to loss of NMP
identity
A small molecule approach was used to investigate whether Myc
activity regulates expression of key components of the WNT/FGF/
Notch network in the CLE/cPSM. To this end, we micro-dissected
explant pairs that contained the NMPs and underlying cPSM from
E8.5 embryos, and cultured them for 6 h in the presence of small
molecule inhibitors that have been extensively used to interfere with
Myc function in vitro (Delmore et al., 2011; Horne et al., 2014;
Posternak and Cole, 2016; Yin et al., 2003). Two different small
molecules, which act via distinct molecular mechanisms, were used
to cross-validate the specificity of our findings: JQ1 is a small
molecule that competitively binds to BRD4, a co-factor that recruits
the Myc complex onto the chromatin (Delmore et al., 2011);
10074G5 interferes with heterodimerization ofMyc with its binding
partner, Max (Yin et al., 2003). As a readout of inhibitor efficacy,
we quantified – by quantitative real-time polymerase chain reaction
(RT-qPCR) – the expression levels of two well-established Myc
targets, cyclin E1 and p21 (Cdkn1a) (Zeller et al., 2003), and found
that upon treatment with either inhibitor, p21 levels were
significantly increased, whereas cyclin E1 levels significantly
decreased (Fig. 3g,h). This is consistent with negative and positive
regulation of p21 and cyclin E1 expression, respectively, as reported
previously (Claassen and Hann, 2000; Gartel et al., 2001; Pérez-
Roger et al., 1997).
We then assessed expression levels of key WNT, FGF and Notch
pathway components using RT-qPCR and ISH. Following Myc
inhibition, a sharp downregulation of Fgf8, Wnt3a/8a and Sox2
transcripts was observed (Fig. 3Aa-b′,f,f′,Ca,b,f). Importantly,
Axin2, Sprouty2 (Spry2), Lfringe and Hes5 expression levels were
unaltered at this 6 h timepoint, revealing that despite the reduction in
FGF andWNT ligand transcripts, WNT, FGF and Notch target gene
expression is not compromised (Fig. 3Ac-d′,B,Cc,d). In addition,
even though Sox2 expression (indicative of NMP identity in this
domain) is affected in the explants, the core epiblast identity [as
judged by Cdx2 and Oct4 (Pou5f1) mRNA expression; Deschamps
and Duboule, 2017] is not affected (Fig. 3Ck,l). Additionally, we
quantified the expression levels of several metabolic genes identified
recently to show high expression in the tail bud (Oginuma et al.,
2017), and found that two of them, triosephosphate isomerase 1
(Tpi1) and enolase 3 (Eno3), show significant downregulation upon
Myc activity suppression, consistent with Myc controlling the
expression of glycolytic genes in other contexts (Hsieh et al., 2015;
Kim et al., 2004; Stine et al., 2015) (Fig. 3Ci,j).
To further corroborate our hypothesis that Myc is important for
the maintenance of WNT/FGF signalling we repeated this
investigation in an NMP-like cell population generated in vitro
from human ESCs (hESCs) (Verrier et al., 2018). Using this
protocol, SOX2/brachyury co-expressing cells can be generated
with high efficiency, while extensive gene expression
characterization, including RNA sequencing, indicates that these
cells faithfully represent the embryonic NMPs (Verrier et al., 2018).
Successful differentiation to the NMP state was verified by
immunofluorescence showing co-expression of Sox2 and
brachyury, and co-expressing cells could be maintained in vitro
for 24 h (Fig. S3). Treatment with 500 nM JQ1 for 24 h resulted in
significant downregulation of SOX2, brachyury,WNT8A, FGF8 and
Fig. 3. Myc activity suppression results in downregulation ofWnt3a/8a, Fgf8 and Sox2. (A) Representative ISH images of CLE/cPSM explants treated with
DMSO (a-f ) or 10 μM JQ1 (a′-f′) for 6 h. Fgf8 (a,a′; n=8/8 embryos),Wnt3a (b,b′; 5/5 embryos) and Sox2 (f,f′; 3/3 embryos) expression is suppressed upon
JQ1 treatment. In contrast, expression of Axin2 (c,c′; n=4/4 embryos), Sprouty2 (d,d′; n=4/4 embryos) and brachyury (e,e′; n=6/6 embryos) is not affected.
(B) Representative ISH images of half-tail explants from E8.5 embryos (micro-dissected below the level of the last somite pair), treated either with DMSOor 10 μΜ
JQ1 for 6 h, showing no effect on expression of the Notch target gene Lfringe (n=4/4 embryos). RT-qPCR analysis of CLE/cPSM explants for Hes5 expression
show no differences upon treatment with 10 μΜ JQ1 or 75 μΜ 10074G5 for 6 h. (C) Characterization of gene expression changes in CLE/cPSM explants
upon 10 μΜ JQ1 or 75 μΜ 10074G5 for 6 h. Relative gene expression, normalized to actin levels, is shown. Data are from three independent experiments, presented
as mean±s.e.m. Statistical significance was assessed using the unpaired two-tailed Student’s t-test for samples with unequal variance. Scale bars: 100 μm.
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cyclin E1, despite the excess of WNT/FGF proteins that are present
in the culture medium of the human NMP-like cells (Fig. 4).
Taken together, these data indicate a specific requirement for
MYC-dependent transcription of key NMP maintenance factors,
namely WNT3A/8A, FGF8 and SOX2.
Alleviation of Myc inhibition is required for neural and
mesodermal differentiation
We next investigated the possibility that transcriptional
downregulation of WNT and FGF protein ligands, following Myc
inhibition, promotes precocious differentiation. Therefore, culture
with 10 μΜ JQ1 was increased to 10 h. Neither Pax6 (a neural
progenitor marker gene) (Stoykova et al., 1996) nor Paraxis (Tcf15)
(a rostral paraxial mesoderm marker) (Burgess et al., 1995)
expression was detected (Fig. 5C). This suggests either that longer
culture is required for differentiation or thatMyc activity is important
for initiation and/or progression of differentiation. To define better
the effects ofMyc inhibition after 10 hwe next assessed the impact of
this treatment on read-outs for FGF and WNT signalling. Indeed we
observed that WNT protein transduction is attenuated, as indicated
by Axin2 transcription; however, expression of the FGF target gene
Sprouty2 is not significantly affected (Fig. 5E).
The effect of Myc inhibition on cell behaviour in these assays was
also addressed. Myc inhibition using JQ1 did not induce apoptosis
as revealed by the terminal deoxynucleotidyl transferase dUTP
nick-end labelling (TUNEL) assay, with positive cells only detected
at the cut edges of explants in both treatment and control conditions
(Fig. 5A). Myc orchestrates the expression of many genes involved
in cell cycle progression (Dang et al., 2006; Eilers and Eisenman,
2008; Zeller et al., 2003, 2006). Analysis of the known Myc target
cyclin E1 indicated a reduction in transcripts following 10 h JQ1
treatment (Fig. 5E). We therefore determined the number of
phospho histone 3 (pH3)-positive cells, indicative of late G2/mitotic
phase (Fig. 5A). We did not observe significant differences in this
time period (Fig. 5B); however, this might be related to the cell
cycle length in NMPs, estimated to be∼7-8 h in the chicken embryo
(Olivera-Martinez et al., 2014), and as such it is perhaps not
surprising that we do not see proliferation impairment following
10 h of Myc activity suppression.
To determine whether the lack of precocious differentiation was
due to a requirement for Myc activity for initiation/progression of
differentiation, we first transiently suppressedMyc using 10 μΜ JQ1
for 10 h, as above, and subsequently washed out the inhibitor and
cultured the explants for a further 14 h, either in plain culturemedium
or in the presence of differentiation stimuli. Washout of Myc
inhibitionwas not sufficient to stimulate expression of differentiation
markers (Fig. S2). To stimulate differentiation towards themesoderm
lineage, we employed the potent GSK3 (GSK3B) antagonist
CT99021 (Cohen and Goedert, 2004). We incubated explants
[previously treated for 10 h with dimethyl sulfoxide (DMSO) or
JQ1] in 30 μΜCT99021 for 14 h and then analysed expression of the
cPSMmarker Tbx6 (Chapman et al., 1996). DMSO control explants
showed high Tbx6 expression, whereas JQ1-treated explants
exhibited very low expression (Fig. 5Da-a′). However, prolonging
exposure to CT99021 for a further 6 h (20 h in total, postremoval of
Myc inhibition) induced high Tbx6 expression in the JQ1-treated
explants. In contrast, at this timepoint, theDMSO-treated explants no
longer expressed Tbx6, likely due to their further differentiation
along the paraxial mesoderm maturation pathway (Fig. 5Db-b′). We
then repeated exactly the same experiment, this time stimulating
retinoid signalling, to promote neural differentiation, using 100 nM
RA for 14 h and 20 h as above. Similarly, JQ1-treated explants were
delayed in their response to upregulate expression of the neural
marker gene Pax6 (Patel et al., 2013; Stoykova et al., 1996) in
response to RA stimulation (Fig. 5Dc,c′,d,d′).
These experiments suggest that Myc directs the expression of
multiple genes within the NMP/cPSM network. One of the gene sets
involves core factors functioning in NMPs (Fgf8, Wnt3a, Wnt8a,
Sox2) and cPSM (Fgf8, Wnt3a) progenitor pool maintenance. The
other gene sets are involved in cell cycle progression ( p21, cyclin
E1) and glycolytic metabolism (Eno3, Tpi1). At the same time, Myc
is required for the differentiation response to external signalling
cues, likely by regulating a different target gene set.
WNT, FGF and Notch signalling converge upstream of cMyc
expression
We then explored what signals regulate cMyc expression in these
domains. cMyc has been shown to be a canonical Notch and WNT
Fig. 4. MYC activity suppression in in vitro
human NMPs results in downregulation of
FGF8,WNT8A, SOX2 and brachyury. 500 nM
of JQ1 was applied for 24 h. Relative gene
expression, normalized to expression of PRT2
is shown. Data are from three independent
experiments, presented as mean±s.e.m.
Statistical significance was assessed using the
unpaired two-tailed Student’s t-test for samples
with unequal variance. *P<0.05.
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protein target in vitro (He et al., 1998; Herranz et al., 2014; Palomero
et al., 2006; Weng et al., 2006), and FGF/ERK (MAPK) genes have
been proposed to act upstream of cMyc transcription (de Nigris et al.,
2001), mRNA stability (Notari et al., 2006) and protein turnover
(Kress et al., 2015; Sears, 2004). In addition, retinoid signalling has
been previously shown to have a negative effect on Myc expression
(Griep and DeLuca, 1986). Here, we employed gain- and loss-of-
function approaches to test whether WNT, FGF or Notch proteins or
RA regulate cMyc transcription in the CLE/cPSM domain.
We first checked whether FGF regulates cMyc by incubating
CLE/cPSM explants for 4 h with 3 μΜ of the MEK inhibitor
PD184352 (Allen et al., 2003) to interfere with FGF signal
transduction, or with recombinant FGF8 protein to stimulate the
endogenous pathway. The expression of Sprouty2, an FGF/ERK
target gene (Sivak et al., 2005; Thisse and Thisse, 2005), was
monitored in parallel as a positive control. Explants in which ERK
protein activity was suppressed showed severe downregulation of
both Sprouty2 and cMyc expression, whereas explants exposed to
exogenous FGF protein showed increased levels of both genes,
indicating a role for FGF proteins upstream of cMyc (Fig. 6Aa-d′).
Next, we tested whether WNT signalling regulates cMyc expression
using 10 μΜ of the known tankyrase inhibitor XAV939 to suppress
WNT signalling (Huang et al., 2009) or WNT3A-conditioned
medium to stimulate WNT signalling. Axin2 was used as a readout
Fig. 5. Myc activity suppression does not promote differentiation, nor does it compromise viability and proliferation. (A) Representative confocal images
of CLE/cPSM explants cultured for 10 h, either in DMSO or in 10 μΜ JQ1 and subsequently stained for pH3 by immunofluorescence (n=3 embryos). The
TUNEL assay was employed to analyse cell death. Apoptotic nuclei were detected in peripheral edges of both DMSO- and JQ1-treated explants (n=3 embryos).
(B) No significant differences in the number of pH3-positive loci were found between DMSO- and JQ1-treated explants (explants micro-dissected from three
different embryos, quantified in 18 optical sections per condition). Data are presented as mean±s.e.m. (C) CLE/cPSM explants treated in DMSO (a-d) or with
10 μΜ JQ1 (a′-d′) for 10 h analysed by ISH. At this timeframe, both Sox2 (n=3/3) and brachyury (n=7/10) expression is downregulated, and differentiation
markers such as Pax6 (n=0/5 embryos) and Paraxis (n=0/3 embryos) are not expressed in control DMSO and JQ1-treated explants. (D) CLE/cPSM explants
after 10 h of culture in DMSO (a-d) or in 10 μΜ JQ1 (a′-b′). Representative ISH images of explants treated with CT99021 (a,b,a′,b′) or 100 nM RA (c,d,c′,d′) for
14 h or 20 h following the 10 h culture in DMSO or 10 μΜ JQ1. Transient Myc suppression for 10 h prior to 14 h of CT99021 stimulation (a′) causes low
levels of Tbx6 mRNA (n=6/6 embryos) compared with DMSO treatment alone (a′). High levels of Tbx6 when CT9901 exposure was prolonged to 20 h
(n=4/4 embryos) (b-b′). Explants transiently incubated with JQ1 express no Pax6 after 14 h of RA treatment (n= 0/6 embryos), in contrast to the DMSO control
explants. Explants transiently incubated with JQ1 do express Pax6 after 20 h of RA treatment (n= 5/5 embryos), as do the control explants. (E) RT-qPCR
analysis of gene expression changes in control CLE/cPSM explants cultured in DMSO or in 10 μΜ JQ1 for 10 h. Relative gene expression, normalized to
actin levels, is shown. Data are from three independent experiments, presented as mean±s.e.m. Statistical significance was assessed using the unpaired
two-tailed Student’s t-test for samples with unequal variance. *P<0.05, **P<0.01, ***P<0.001; ns, nonsignificant. Scale bars: 100 μm.
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forWNTactivity (Jho et al., 2002). Similarly to the FGFexperiment,
we found that Axin2 and cMyc were both downregulated following
XAV939 treatment and were both upregulated in response to
exogenous WNT signalling (Fig. 6Ba-d′). We used the γ-secretase
inhibitor LY411575 to inhibit Notch signalling (Curry et al., 2005)
and found that the expression of both Lfringe (Notch target gene)
(McGrew et al., 1998) and cMyc was lost in the treated explants
(Fig. 6C). Finally, culture of CLE/cPSM explants with 100 nM RA
for 6 h reduced Fgf8 levels, as previously reported (Diez del Corral
et al., 2003); however, it did not change cMyc levels, suggesting that
within these progenitors it is unlikely that RA acts upstream of cMyc
(Fig. 6D).
These experiments suggest that the three segmentation clock
pathways (WNT, FGF and Notch) converge in regulating cMyc
transcription in the NMPs and cPSM. Given the extensive crosstalk
between these pathways (Akai et al., 2005; Bone et al., 2014; Katoh,
2007; Stulberg et al., 2012), each pathway could be acting directly
or indirectly to regulate cMyc expression.
Fig. 6. cMyc is co-regulated byWNT, FGF and Notch signals and Myc activity suppression results in delays in somite formation. (A) Representative ISH
images of CLE/cPSM explants cultured for 4 h in DMSO (a,b) or with 3 μΜ PD184352 (a′,b′) to block ERK phosphorylation. Sprouty2 (n=5/5 embryos) and cMyc
(n=5/6 embryos) expression is downregulated in the PD184352-treated explants. Stimulation of FGF signalling using 250 ng/ml recombinant FGF8 protein
for 8 h results in upregulation of both Sprouty2 (n=5/8 embryos) and cMyc (n=5/9 embryos) in CLE/cPSM explants (c′,d′), when compared with control explants
cultured in PBS (c,d). (B) Representative ISH images of CLE/cPSM explants cultured for 4 h in DMSO (a,b) or 10 μΜ XAV939 (a′,b′) to block tankyrase activity.
Axin2 (n=7/7 embryos) and cMyc (n=4/5 embryos) expression is downregulated in the XAV939-treated explants. Stimulation of WNT signalling using WNT3A-
conditioned culture medium for 6 h results in upregulation of both Axin2 (n=3/3 embryos) and cMyc (n=3/3 embryos) in CLE/cPSM explants (c′,d′) when
compared with control explants cultured in DMSO (c,d). (C) Representative ISH images of E8.5 half-tail explants (micro-dissected at the level below the last
formed somite) cultured for 4 h in DMSO (a,b) or CLE/cPSM explants cultured in the presence of 150 nM LY411575 (a′,b′) to block γ-secretase activity.
Lfringe (n=4/4 embryos) and cMyc (n=4/4 embryos) expression is downregulated in the LY411575-treated explants compared with controls. (D) RT-qPCR
quantification of cMyc and Fgf8 expression in CLE/cPSM cultured for 6 h in DMSO or 100 nM RA. Relative gene expression normalized to actin levels is
shown. Data are from two independent experiments, presented asmean±s.e.m. (E) Representative images of E9.5 half-tail explants treated with 10 μΜ JQ1 (a) or
with 75 μΜ 10074G5 (b) for 4 h, labelled by ISH for the Notch clock gene Lfringe. Myc inhibition delayed Lfringe phase pattern expression (11/16 explants treated
with JQ1, 4/5 explants treated with 10074G5). (F) Western blot analysis of NICD levels in E9.5 embryo tails. Tails treated with JQ1 or 10074G5 for 4 h show
increased NICD levels when compared with control DMSO tails cultured in parallel. Culture in the presence of 150 nM LY411575 for 4 h completely abolishes
NICD as expected. Addition of 150 nM LY411575 for the last 1 h of culture depletes NICD only in the DMSO sample, whereas samples treated with JQ1 or
10074G5 exhibit higher levels of NICD. (G) RT-qPCR quantification of Notch1 and Dll1 expression in control CLE/cPSM explants cultured for 6 h in DMSO,
or in CLE/cPSM explants cultured in parallel in 10 μΜ JQ1 or 75 μΜ 10074G5, reveals no significant changes in expression. Relative gene expression,
normalized to actin levels, is shown. Data are from three independent experiments, presented as mean±s.e.m. Statistical significance was assessed using the
unpaired two-tailed Student’s t-test for samples with unequal variance. ns, nonsignificant. Scale bars: 100 μm.
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Myc inhibition delays clock gene oscillations and slows
somitogenesis
We then tested whether Myc plays a role in somitogenesis. We
bisected E9.5 tails and incubated them for 4 h, with one half
cultured in the presence of DMSO and the other in the presence of
10 μΜ JQ1 or 75 μΜ 10074G5. We then analysed the phase
expression patterns of the Notch target clock gene, Lfringe, in the
tail explants. Control explants formed at least one new somite pair
during the 4 h incubation; however, Myc-inhibited explants
displayed delayed Lfringe oscillations as compared with their
control counterparts and, in some cases, also formed fewer somites
(Fig. 6E).
We have previously published that regulation of Notch1
intracellular domain (NICD) turnover regulates the period of
clock gene oscillations (Wiedermann et al., 2015). To see whether
the observed delay in somite formation and clock gene oscillations
upon Myc inhibition is linked to Notch signalling, we analysed
levels of NICD in E9.5 tails cultured for 4 h in the presence or
absence of Myc inhibitors by western blotting. Tail lysates
incubated with either of the two small molecule inhibitors
displayed higher levels of NICD, when compared with DMSO-
treated tail lysates (Fig. 6F). To investigate whether the increased
NICD levels result from new NICD production, we first incubated
the explants with JQ1 or 10074G5 for 3 h and subsequently added
the γ-secretase inhibitor LY411575 for 1 h. Control DMSO explants
showed depletion of the NICD protein, whereas explants in which
Myc activity was suppressed showed elevated NICD levels
(Fig. 6F). Previously cMyc has been shown to repress Notch1
transcription (Zinin et al., 2014). To test whether the increased
NICD levels result from increases in Notch1 or delta 1 (Dll1)
transcription, we analysed Notch1 and Dll1 levels in CLE/cPSM
explants treated for 6 h with 10 μΜ JQ1 or 75 μΜ 10075G5. We
did not find significant changes in Notch1 or Dll1 transcript
levels (Fig. 6G). These data suggest that the increases in NICD
levels following Myc activity suppression are post-translational
effects, and not a result of increased levels of Notch1/Dll1
transcription.
Conditional inducible cMyc depletion results in reduction of
Fgf8 expression levels
To study these diverse functions in vivo, we generated a conditional
inducible mouse line to specifically genetically ablate cMyc
expression in a spatially and temporally controlled manner from
the tail of the postimplantation embryo. We employed an available
transgenic cMycmouse line, in which loxP sites have been placed on
either side of exons 2 and 3 of the cMyc locus (Trumpp et al., 2001;
hereafter referred to as the cMycFL/FL allele). To specifically ablate
cMyc from the embryonic tail, we used an available mouse line in
which ERT2-CRE expression is conditionally under the control of
the Nkx1-2 promoter (Rodrigo Albors et al., 2016 preprint). Nkx1-2
starts to be expressed in the CLE associated with the anterior
primitive streak at E7, and continues to be highly transcribed here and
at declining levels in the pre-neural tube domain at E8.5 (Rodrigo
Albors et al., 2016 preprint). Tamoxifen-induced homologous
recombination through CRE recombinase activity results in
excision of the two exons and loss of function of the cMyc genetic
product (Trumpp et al., 2001). Visualization of the CRE activation
domain was possible through immunofluorescence labelling for
the YFP protein; the YFP allele, controlled by the Rosa26 promoter,
was activated for expression upon CRE-mediated excision of a
loxP-flanked STOP sequence located upstream of the YFP locus
(Rodrigo Albors et al., 2016 preprint; Srinivas et al., 2001).
Using ISH on E8.5 embryos, we verified a complete loss of cMyc
transcript in the CLE of cMyc KO embryos, whereas gene expression
was present in the somites and head (Fig. S4A). In addition,
immunofluorescence labelling for GFP revealed intense staining in
the CLE domain, with a few cells labelled in the neural tube, in
accordancewith Rodrigo Albors et al. (2016 preprint). The cMyc KO
embryos at E8.5 were indistinguishable from control wild-type
embryos, and loss of cMyc did not affect formation of the PSM,
somites and neural tissue. These experiments suggest that acute
cMyc loss from the E8.5 CLE does not affect short-term embryo
development.
To investigate whether loss of cMyc from the E8.5 tail region
affects embryogenesis during body axis elongation, we collected
E9.5, E10.5 and E11.5 embryos. We found that cMyc KO embryos
were of normal morphology, and formed all CLE derivatives (PSM,
somites and neural tissue) (Fig. 7Aa,Ba′). In addition, the somite
number and size, and the neural tube area and cell density, were not
affected in embryos inwhich cMycwas conditionallyablated (Fig. 7).
Expression analysis of key genes that were affected in the explant
experiments revealed a profound reduction of Fgf8 PSM expression
in E9.5 cMyc KO embryos (n=5 embryos) (Fig. S4B). In particular,
expression was severely downregulated in the overlying caudal-
most neuroepithelium, whereas the PSM was completely devoid of
expression. Similarly, E10.5 cMyc KO embryos exhibited normal
morphology, with severely reduced Fgf8 PSM expression compared
with that of control embryos (n=3/3 embryos) (Fig. 7Ab-e,Bb′-e′).
Fgf8 expression was spared only in the mesodermal compartment of
the CNH (Fig. 7Bf′). Fgf8 expression in the limb buds of E10.5
cMyc KO embryos was unaffected compared with that of controls
(Fig. 7Aa-c,Ba′-c′).
To address whether cMyc depletion and subsequent Fgf8
downregulation affected the presence or number of Sox2/brachyury
co-expressing NMP cells, we carried out immunofluorescence
labelling in E10.5 tails for Sox2, brachyury and GFP. GFP-
expressing cells in the tail bud (indicative of cMyc depletion) still
co-expressed Sox2 and brachyury, in a similar manner to wild-type
embryos, suggesting that cMyc-mediated loss of Fgf8 throughout
almost all of the tail end of the embryo is insufficient to directly affect
the NMP identity (Fig. 7Ag-r,Bg′-z′). Quantification of the Sox2/
brachyury cells in tail bud sections of control and cMyc KO embryos
did not reveal any differences (Fig. 7C). Interestingly, the
mesenchymal domain that still expresses low levels of Fgf8 in the
cMyc KO embryos (Fig. 7Bf′) is almost devoid of GFP-expressing
cells (Fig. 7Bs′), in accordancewith thework of RodrigoAlbors et al.
(2016 preprint), which showed that Nkx1-2-expressing cells do not
contribute to this mesoderm compartment of the CNH. These FGF8-
positive cells might serve, in part, tomaintain theNMPprogenitors in
the KO embryos. To further decipher whether other NMP regulatory
factors could compensate forFgf8 loss, we checked the expression of
Wnt3a in KO embryos. Expression of this gene appeared unaffected
(Fig. S4), suggesting that further compensatorymechanisms safeguard
expression of this gene. It is possible that the prolonged persistence of
the Fgf8 mRNA (Dubrulle and Pourquié, 2004), which is still
expressed at low levels in the cMyc KO embryos, could indirectly
promoteWnt3a expression, as extensive crosstalk between WNT and
FGF signals has previously been reported in these tissues (Aulehla and
Pourquié, 2010; Gibb et al., 2010; Henrique et al., 2015).
DISCUSSION
cMyc has been reported to be expressed in the early
postimplantation epiblast (Clavería et al., 2013; Sancho et al.,
2013) and to be a pluripotency factor in ESCs (Chappell and Dalton,
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2013). The pluripotency factor Oct4 is still expressed in the CLE at
E8.5, whereas its expression is downregulated at E9.5 (Aires et al.,
2016). Thus, cMyc expression in the CLE coincides with the
presence of other known pluripotency factors (Sox2, Oct4), further
highlighting that the CLE shares characteristics of the early
pluripotent epiblast (Gouti et al., 2015; Henrique et al., 2015).
However, in contrast to Oct4 (Aires et al., 2016), we found that
cMyc continues to be expressed in the tail bud during tail growth
stages. We found that Myc functions to promote expression of
factors that maintain the NMP pool (by sustaining Wnt3a/8a and
Fgf8 expression) and the NMP identity (Sox2/brachyury co-
expression) by promoting Sox2 expression. Interestingly, cMyc
has been shown to positively regulate Sox2 expression (Lin et al.,
2009) and to directly promote WNT signalling in mouse pluripotent
stem cells (PSCs) (Fagnocchi et al., 2016). In the same context,
cMyc is WNT regulated, and establishes a positive feedback WNT
network that is indispensable for identity maintenance (Fagnocchi
et al., 2016; Fagnocchi and Zippo, 2017). Similarly, our work shows
that both WNT and FGF converge upstream of cMyc transcription
suggesting that cMyc could be establishing and maintaining a Myc/
WNT/FGF network operating in the NMPs. Given that secreted
WNT/FGF act on the underlying mesoderm and control PSM
maturation, it is possible that the aforementioned network operates
in both of these adjacent progenitor domains (NMPs/cPSM), even
though active transcription (of at least a subset of FGF components)
is restricted to the overlying CLE (Dubrulle and Pourquié, 2004). In
Fig. 7. Conditional inducible cMyc depletion from the CLE results in downregulation of Fgf8 expression during axis elongation. (A) (a-f ) Representative
images of E10.5 control embryos (n=3 embryos) labelled by ISH for Fgf8 expression show high expression levels in the hind limbs and in the tail bud.
(c) Transverse section in the limb bud region demarcated by thewhite dashed line in b. (d-f ) Transverse sections of the CNH and tail bud demarcated by thewhite
dashed line box in b. (g-r) Confocal images of transverse sections of the CNH and tail bud labelled by immunofluorescence for Sox2 and brachyury,
showing a large number of co-expressing cells in the tail bud mesenchyme (data from ten confocal sections from two embryos). (B) Representative images of
E10.5 cMyc conditional inducible mutant embryos (n=3 embryos) labelled by ISH for Fgf8 expression. (a′-f′) High levels of Fgf8 are detected in the hind limbs,
whereas very low levels are detected in the tail bud. (c′) Transverse section in the limb bud region demarcated by thewhite dashed line box in b′. (d′-f′) Transverse
sections of the CNH and tail bud demarcated by the white dashed line box in b′. (g′-z′) Confocal images of transverse sections of the CNH and tail bud
labelled by immunofluorescence for Sox2, brachyury and GFP show large numbers of co-expressing cells in the tail bud mesenchyme. GFP cells are mostly
absent from the CNH (s′), whereFgf8 expression is still detected (f′) (data from ten confocal sections from two embryos). Scale bars: 100 μm. (C) Quantification of
Sox2/brachyury co-expressing tail bud cells in control (n=2; eight sections) and cMyc KO (n=2; eight sections) embryos did not reveal differences. The counts are
normalized to the total number of DAPI-stained nuclei. (D) Measurements of the neural tube (NT) area and cell density did not reveal differences between control
(n=2; 25 sections) and cMyc KO embryos (n=2; 18 sections). (E) No differences between somite number (counted below hind limb level) or size were found
between control (n=5) and cMyc KO embryos (n=8).
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addition to WNT and FGF, we found that Notch activity is also
important for cMyc transcription, in alignment with other published
work identifying cMyc as a canonical Notch protein target, where
again it operates in a positive feedforward loop (Palomero et al., 2006).
Very recently, two independent studies have highlighted a novel
role for glycolytic metabolism during axis elongation (Bulusu et al.,
2017; Oginuma et al., 2017). Inhibition of glycolysis resulted in loss
of NMPs, premature differentiation towards the neural lineage and
cessation of elongation (Oginuma et al., 2017). Myc is involved in
the regulation of metabolism (Clavería et al., 2013; Dang et al.,
2006; Eilers and Eisenman, 2008; Fagnocchi and Zippo, 2017;
Hsieh et al., 2015), while recently, cMyc was found to link FGF
signalling and glycolysis during vascular development in mice (Yu
et al., 2017). In our study, we found that Myc activity is crucial for
maintenance of mRNA levels of two key glycolytic genes (Tpi1,
Eno3) that have been shown to exhibit graded rostrocaudal
expression along the PSM (Oginuma et al., 2017). Taken
together, these data suggest that, in the NMP and cPSM
populations, Myc activity might regulate progenitor pool
maintenance through the integration of proliferative WNT/FGF
signals, as well as regulation of a specific subset of metabolic genes.
A striking finding was that Myc inhibition delayed dynamic clock
gene expression across the PSM, which also coincided with
increases in NICD levels. Interestingly, Myc activity suppression
did not result in significant changes in Notch1 mRNA levels, in
contrast to a previous study indicating that cMyc is a negative
regulator of Notch1 expression in the chicken embryo neural tube
(Zinin et al., 2014). A possible explanation for how Myc might
affect NICD levels in the PSM could be through negative regulation
of proteins mediating NICD turnover. We have previously shown
that WNT or CDK protein inhibition (Gibb et al., 2009;
Wiedermann et al., 2015) delays the periodicity of dynamic
Lfringe clock gene expression across the PSM and that this
phenotype is linked to inefficient NICD turnover. Given we
demonstrate here that cMyc expression is WNT regulated in this
tissue, and we find that Myc regulates transcription of the CDK
inhibitor p21, it is possible to hypothesize thatMyc acts downstream
of WNT signalling and upstream of p21, which in turn controls
downstream CDKs that regulate NICD phosphorylation and
subsequent turnover. It would be interesting to investigate further
whether Myc activity is crucial for proper timing of FGF and WNT
‘clock’ gene oscillations, which would provide insight into how the
segmentation clock pathways are mechanistically linked.
Because cMyc is highly expressed in the CLE and persists in the
tail bud (in contrast to MycN), we chose to acutely deplete cMyc
from the embryonic tail region and study possible defects caused
during the body axis elongation stages. Global cMyc KO embryos,
are smaller than wild-type embryos and display multiple defects
including abnormalities in neural tube closure (Davis et al., 1993).
They do, however, survive to E10.5, possibly due to compensatory
activity of MycN (Trumpp et al., 2001). However, Sox2-driven
conditional cMyc depletion from the early mouse epiblast does not
compromise embryo viability up to E11.5, and only confers defects
in the hematopoietic lineage (Dubois et al., 2008). Here, we were
able to highlight a direct requirement for cMyc, as a transcriptional
regulator of Fgf8 in the caudal neuroepithelium and tail bud in
regions in which the Sox2/brachyury co-expressing NMPs reside.
Fgf8 expression was spared only in the mesodermal compartment of
the CNH of KO embryos. Despite Fgf8 loss throughout most of this
caudal domain, the NMP pool was not compromised (at least at
E10.5), which could be attributed either to compensation from the
low level of FGF8 remaining, or other FGF factors that are present in
the embryonic tail (Boulet and Capecchi, 2012; Naiche et al., 2011),
or to uninterrupted WNT activity (for example through Wnt3a),
which was not affected following genetic depletion of cMyc in this
region and has been shown to be crucial for the NMP pool
maintenance (Garriock et al., 2015). In addition, FGF8 has been
previously shown to be dispensable for body axis elongation in the
mouse (Perantoni et al., 2005), even though it is required for initial
body axis specification and mesoderm migration through the
primitive streak (Sun et al., 1999).
In summary, the current work uncovered multiple novel functional
roles for Myc activity during body axis elongation. Future work
should focus on deciphering the global Myc transcriptional signature
within the progenitors that mediate this process.
MATERIALS AND METHODS
Mouse embryo collection and explant dissection
Pregnant female CD1 (between 10-20 weeks of age) mice were culled by
cervical dislocation and the uteri were dissected and collected in phosphate
buffered saline (PBS). Embryos of either 8.5, 9.5, 10.5 or 11.5 days
postcoitum (dpc) were washed in Leibovitz’s L15 medium (Life
Technologies) or Dulbecco’s modified Eagle medium (DMEM)-F12
+0.1% Glutamax medium (Life Technologies), and collected in L15 or
DMEM-F12 supplemented with 5-10% fetal bovine serum (FBS; Life
Technologies. All animal procedures were approved by the Animal
Scientific Procedures Act (1986, amended 2012).
For E8.5 CLE/cPSM explant dissection, mouse embryos were collected
in L15 medium (Life Technologies). The embryos were first staged
according to the somite number, and embryos at the five- to seven-somite
stage were used. The tissue flanking the node and rostral to the tail bud
mesoderm, which included the CLE and underlying mesoderm, was
dissected and subsequently bisected along the longitudinal axis of the
embryo to give right and left caudal embryo explant pairs. The explants were
then individually embedded in freshly prepared rat tail-derived collagen mix
[consisting of 71.5% rat tail collagen (Corning), 23.8% 5× L15, 23.8%
acetic acid, 4.7% NaHCO3], and cultured for the appropriate timeframe at
37°C in a controlled atmosphere of 5% CO2 in air, in a culture medium
consisting of Optimem (Life Technologies) supplemented with 5% FBS,
2 μΜ glutamine and 50 μΜ/ml gentamycin. For each pair, one explant was
cultured in the appropriate volume of DMSO diluted in the above culture
medium or in culture medium supplemented with the appropriate dilution of
a small molecule inhibitor to suppressMYC [JQ1; a kind gift to K.G.S. from
Dr James E. Brander (Harvard Medical School, MA, USA)] or 10074G5
(Sigma-Aldrich), WNT, Notch or FGF/ERK protein activity, as described in
Table 1. For WNT signalling stimulation, the culture medium used was
derived from L Cells (ATCC CRL-2648; hereafter referred to as control
medium), or a DMEM-based WNT3A-enriched medium derived from L
Wnt-3A cells (ATCC CRL-2647; hereafter referred to as WNT-conditioned
medium) [supplemented with 10% FBS (Labtech), 2 mM L-glutamine
(Lonza) and 1% penicillin/streptomycin (Lonza)] that had been prepared
in house. For FGF stimulation experiments, recombinant h/m FGF8
(250 ng/ml; R&D Systems) was employed, as described in Diez del
Corral et al. (2003).
At the end of the culture time, the embedded explants were fixed in
4% formaldehyde (Sigma-Aldrich) or 4% paraformaldehyde (Electron
Microscopy) diluted in PBS, either for 2 h at room temperature or overnight
at 4°C, if they were to be processed for ISH or for 2 h at 4°C if they were to be
processed for immunofluorescence. They were directly lysed in RLT Buffer
(Qiagen) if they were to be processed for RT-qPCR analysis. E9.5 half tail
explants were micro-dissected and cultured as described in Bone et al. (2014).
Differentiation of CLE/cPSMexplants fromE8.5 embryos towards
mesoderm or neural lineages
CLE/cPSMexplants derived fromE8.5 embryoswere cultured for 10 h at 37°C
as described above. At the end of the 10 h incubation, both control (DMSO)
and JQ1-treated collagen-embedded explants were rinsed in clean PSB
and washed in PBS twice for 5 min. Subsequently, fresh culture medium
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[Optimem (Life Technologies), 5% FBS, 2 μΜ glutamine and 50 μΜ/ml
gentamycin] supplemented either with 30 μΜ CT9901 (Tocris) or with
100 nM RA (Sigma-Aldrich) was added to the explants and they were further
cultured for 14 h or 20 h at 37°C in a controlled atmosphere of 5% CO2 in air.
At the end of the culture time, the explants were fixed in 4% formaldehyde
(Sigma-Aldrich) or 4% paraformaldehyde (Electron Microscopy) diluted in
PBS, overnight at 4°C, and were processed for ISH.
ISH
For ISH, the embryos and embryo-derived explants were first fixed
overnight in 4% PFA at 4°C. ISH was carried out following standard
procedures.
Colour revelation was performed after an overnight incubation with a
1:1000 dilution of the anti-digoxigenin antibody conjugated to alkaline
phosphatase (Anti-Digoxigenin-AP, Fab fragments, Promega). Wild-type
and genetically modified embryos were always treated in parallel and colour
revelation was initiated and stopped simultaneously. Control and inhibitor-
treated explants derived from each embryo were fixed simultaneously in 4%
PFA and processed for ISH in parallel. Each explant pair was always treated
simultaneously for colour revelation, which was stopped simultaneously for
both explants. Colour revelation was stopped when adequate colour had
developed in either the control or the treated explant of each pair. In the gain-
of-function experiments for FGF and WNT stimulation, the treated explants
were reproducibly saturated in each case, as they developed a lot faster than
the control explants coloured in parallel. Explant expression data were
double scored by two laboratory members independently.
Immunocytochemistry
E8.5 whole mount, cryosections or explants of embryos were stained for
immunofluorescence using primary antibodies against Sox2 [neural marker,
raised in goat (Immune Systems, GT15098; LOT 909901)], brachyury
[mesoderm marker, raised in rabbit (Santa Cruz Biotechnology, H-210; LOT
H2514); or raised in goat (R&D Systems, AF2085; LOT KQP0319031)] and
pH3 (Upstate Cell Signaling Solutions, 06-570; LOT32219). cMyc-positive
cells were labelled using the monoclonal anti-c-Myc antibody [raised in rabbit
(Abcam, Y69; LOT GR255057-5)]. Briefly, embryos and explants were
blocked overnight in 10% heat-inactivated donkey serum (Sigma-Aldrich)
diluted in PBT (1% Tween, 1% Triton, 2% bovine serum albumin diluted in
PBS) at 4°C. All primary antibodies were used at a final concentration of
1:200 in blocking solution, and the embryos or explants were incubated
overnight at 4°C. Following washes with PBST, the anti-donkey fluorescently
conjugated secondary antibodies Alexa Fluor 488 and Alexa Fluor 594
(Invitrogen) were added at a final dilution of 1:200 in blocking solution and
the tissues were incubated overnight at 4°C. Nuclei were counterstained using
4′,6-diamidino-2-phenylindole (DAPI) at a final dilution of 1:1000.
TUNEL assay
The TUNEL assay was performed following a standard protocol optimized
for tissue processing and using the ApopTag Kit (Millipore) according to
the manufacturer’s instructions.
Culture and differentiation of H9 hESCs (PSCs) to generate
NMP-like cells
H9 (WA09) hESCs were purchased fromWicell and supplied at passage 24.
The cells were thawed, transferred to DEF medium (Cellartis AB) and cell
banks were prepared at passage 29. For routine production, the cells were
used between passage 29 and 39. For quality control purposes, representative
lots of the cell bank were thawed and tested for post-thaw viability, and to
ensure sterility and absence of mycoplasma contamination. After two
passages, the cell lines were tested for the expression of pluripotency
markers (Oct4, Sox2, Nanog, SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81)
and differentiation markers [SSEA-1 (Fut4), HNF-3 beta (Foxa2), beta-III-
tubulin and smooth muscle alpha-actinin] by immunofluorescence, and the
ability to form all three germ layers when embryoid bodies are allowed to
spontaneously differentiate in culture (immunofluorescence for HNF-3 beta,
beta-III-tubulin and smooth muscle alpha-actinin).
H9 hESCs were maintained as feeder-free cultures in DEF-based
medium (Cellartis DEF-CS) supplemented with 30 ng/ml bFGF
(Peprotech) and noggin (10 ng/ml, Peprotech) on fibronectin-coated
plates, and enzymatically passaged using TryPLselect (Thermo Fisher
Scientific), and differentiated to the NMP-like state following the
protocol from Verrier et al. (2018). All experiments with hESCs were
approved by the UK Stem Cell Bank Steering Committee (SCSC14-28
and SCSC14-29).
Image acquisition and analysis
Images of fluorescently labelled whole mounts, sections and explants of E8.5
embryos were taken using a Zeiss 710 confocal microscope equipped with a
LASOS camera. Images of ISH were acquired using the Leitz DM RB Leica
microscope, which is equipped with a Nikon D1X camera. Sox2/brachyury
co-expressing cells and DAPI-positive nuclei were manually counted using
ImageJ (https://imagej.nih.gov/ij/). Figure preparation was carried out using
the free online software OMERO (www.openmicroscopy.org).
RT-qPCR
Total RNA fromH9 human PSCs and human NMPs or derived explants (6×
CLE/cPSM explants per sample) was purified using an RNeasy Mini Kit
(Qiagen) following the manufacturer’s instructions, and the concentration
and quality of the eluted RNA was determined using the NANOdrop
System. cDNA synthesis was performed using the Superscript III Kit
(Invitrogen) in 0.25 μg, 0.5 μg or 1 μg of purified RNA according to the
manufacturer’s instructions. RT-qPCR was performed using 1 μl of
synthesized cDNA and 9 μl of Power SYBR Green PCR Master Mix
(Life Technologies/Fisher), diluted in which were primers against the gene
of interest (Table S1). ACFX96 thermocycler (Bio-Rad) was used for target
cDNA amplification. Dilution curves for each primer set were performed to
ensure that the primers were working at 100% efficiency, and the del-delcT
method (Livak and Schmittgen, 2001) was used to analyse gene expression
levels. Statistical significance was assessed either with the Student’s t-test or
with analysis of variance (ANOVA).
Table 1. Summary of embryo explant treatments
Embryo stage Treatment Concentration Incubation Mode of action
E8.5/E9.5 JQ1 10 μM 6 h or 10 h/4 h Binds to BRD4 protein, suppressing Myc-dependent transcription.
E8.5/E9.5 10074-5G 75 μM 6 h/4 h Binds to Myc proteins, preventing heterodimerization with Max.
Results in Myc activity suppression.
E8.5 LY411575 150 nM 4 h Inhibits activity of γ-secretase resulting in Notch pathway suppression.
E8.5 XAV939 10 μM 4 h Inhibits activity of tankyrase leading to Axin2 protein stabilization
and shut down of WNT pathway signal transduction.
E8.5 PD184352 3 μM 4 h Prevents phosphorylation of ERK1 (MAPK3).
E8.5 Human or mouse FGF8B 250 ng/ml 8 h Recombinant ligand that stimulates the FGF signalling cascade.
E8.5 WNT3A-conditioned medium Unspecified 6 h Recombinant ligand that stimulates the WNT signalling cascade.
E8.5 CT9901 30 μM 14 h or 20 h Potent GSK3 antagonist that results in WNT signalling stimulation.
E8.5 trans-RA 100 nM 14 h or 20 h RA diffuses through cell membranes and directly regulates gene
transcription by associating with nuclear RA receptors (RARs), which
in turn bind to specific DNA sequences called RA response elements
(RAREs), located in enhancer regions of RA targets.
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Western blotting of mouse E9.5 embryo tails
Protein extraction and western blotting was carried out following standard
procedures using 10 μg of protein and the following dilutions of antibodies:
1:1000 of the rabbit anti-mouse NICD (Cell Signaling Technology) and
1:10,000 mouse β-actin (Proteintech).
Generation of the inducible conditional cMyc mouse line
In order to genetically deplete cMyc from the tail end of the embryo, we
utilized two available C56 mouse lines. One previously generated in the
laboratory (Rodrigo Albors et al., 2016 preprint), in which CRE
recombinase expression is driven under the control of the Nkx1-2
promoter (hereafter referred to as the Nkx1-2ERT2_CRE locus), which also
carried a LoxP-flanked STOP sequence upstream of a EYFP reporter
transgene of the Rosa26 ubiquitous promoter (hereafter referred to as the
YFP locus) (Rodrigo Albors et al., 2016 preprint; Srinivas et al., 2001), and
one in which LoxP sites have been placed on either side of exons 2 and 3 of
the cMyc locus (hereafter referred to as the cMyc FLOXN locus) (Trumpp
et al., 2001). Homozygote mice for the cMyc FLOXN, Nkx1-2ERT2_CRE, YFP
alleles were morphologically normal and indistinguishable from C57 wild-
type mice. Induction of homologous recombination was achieved by
administering 200 μl of tamoxifen (Sigma-Aldrich), diluted in 10% ETOH/
90% vegetable oil in a final concentration of 40 μg/ml, to the pregnant
mother on 6 dpc and 7 dpc by oral gavage. Embryos were collected and
analysed on 8.5, 9.5, 10.5 and 11.5 dpc. Validation of the region in which
the cMyc locus was knocked out was achieved by immunofluorescence
labelling against the YFP protein and by ISH against cMyc. Throughout the
generation and maintenance of the mouse colony, ear biopsies were
dissected from mouse pups for genotyping. DNAwas extracted from the ear
biopsies by direct addition of 20 μl of the MICROLYSIS mix (Cambio) in
the biopsy sample. The PCR programs and primer sets for detection of the
cMyc FLOXN locus are from Trumpp et al. (2001) and those for the Nkx1-
2ERT2_CRE and YFP alleles are from Rodrigo Albors et al. (2016 preprint).
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